Results 181 to 190 of about 28,017 (205)

hCMV-Specific CD8+ T Cells in Lymph Nodes from Renal Transplant Recipients Contain ‘True’ Memory Cells

open access: bronze, 2012
Ester B. M. Remmerswaal   +12 more
openalex   +1 more source

VIGILÂNCIA CLINICO-LABORATORIAL DA INFECÇÃO PELO HERPESVÍRUS HUMANO 6 (HHV-6) E HERPESVÍRUS HUMANO 7 (HHV-7) E DA CO-INFECÇÃO COM CITOMEGALOVÍRUS HUMANO (HCMV) APÓS O TRANSPLANTE HEPÁTICO

open access: diamond, 2012
Ana Maria Sampaio   +11 more
openalex   +2 more sources

Correction: HCMV Activates the IL-6-JAK-STAT3 Axis in HepG2 Cells and Primary Human Hepatocytes

open access: gold, 2013
Quentin Lepiller   +4 more
openalex   +2 more sources

Human cytomegalovirus (HCMV)-specific immunoglobulin E as a serologic marker for HCMV infection in immunocompromised patients [PDF]

open access: bronzeThe Clinical Investigator, 1992
An antibody capture assay using an enzyme-linked human cytomegalovirus (HCMV) antigen for the detection of specific immunoglobulin E (IgE) was established. IgG, M, and E responses to HCMV were studied in 497 sera obtained from 44 renal transplant recipients and 51 acquired immunodeficiency syndrome (AIDS) patients.
W. Braun   +4 more
openaire   +4 more sources

First-line therapy with donor-derived HCMV-specific T cells reduces persistent HCMV infection by promoting antiviral immunity after allogenic stem cell transplantation.

Clinical Infectious Diseases, 2020
BACKGROUND Human cytomegalovirus (HCMV) infection, especially persistent HCMV infection, is an important cause of morbidity and mortality after allogenic stem cell transplantation (allo-SCT). Antiviral agents remain the first-line therapy but are limited
Xiang-Yu Zhao   +8 more
semanticscholar   +1 more source

Adoptive immunotherapy of HCMV infection

Cytotherapy, 2007
Human cytomegalovirus (HCMV) infection or reactivation is a frequent cause of morbidity and mortality in immunocompromised individuals such as transplant recipients. Primary HCMV infection or reactivation of HCMV from latency is mostly asymptomatic in immunocompetent individuals and is controlled by the host's cell-mediated immune response.
Götz Ulrich Grigoleit   +3 more
openaire   +3 more sources

Human cytomegalovirus (HCMV) long-term shedding and HCMV-specific immune response in pregnant women with primary HCMV infection

Medical Microbiology and Immunology, 2022
Human cytomegalovirus (HCMV) shedding has been extensively investigated in newborns and in young children, however, much less is known about it in immunocompetent adults. Shedding of HCMV was investigated in saliva, vaginal secretions and urine of pregnant women experiencing primary infection along with the development of the HCMV-specific immune ...
C. Fornara   +8 more
openaire   +3 more sources

Specificity for HCMV strains

Nature Reviews Immunology, 2018
Strain-specific recognition of different UL40 peptides determines the proliferation and activation of NKG2C+ NK cells during HCMV infection.
openaire   +3 more sources

Home - About - Disclaimer - Privacy